Procter & Gamble (PG) Health Care CEO Gama Paul Receives Award

What Happened Gama Paul, Procter & Gamble's CEO — Health Care, was granted equity awards in mid‑August 2026. The filing reports an award of 7,727 shares on 2026-08-19 and a derivative award of 7,095 restricted stock units (RSUs) on 2026-08-17. Both items were reported as acquisitions at $0.00 (awards/compensation), so no cash was paid by the insider.

Key Details

• Transaction types: A = Award/Grant (one grant of shares, one grant of RSU-style derivative units).
• Dates and reported prices:
  • 2026-08-19: 7,727 shares acquired at $0.00.
  • 2026-08-17: 7,095 RSU units acquired at $0.00 (reported as a derivative award).
• Report filed: Accession 0000080424-26-000135, Form 4 filed 2026-08-20 for transactions through 2026-08-19 (appears timely).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnotes (summary):
  • F1: Stock award made under the issuer’s 2025 Stock and Incentive Compensation Plan.
  • F2: Total includes dividend equivalents awarded as RSUs settled in common stock.
  • F3: Some dividend-equivalent RSUs were previously awarded under the company’s retirement program and represent contingent rights to receive P&G stock.
  • F4: Those retirement-related units typically convert to shares upon the reporting person’s retirement unless delivery is deferred or contributed to a deferred compensation account.

Context These entries are compensation awards, not open‑market purchases or sales. RSU/derivative grants represent a contingent right to receive shares in the future (often subject to vesting or retirement conditions) and do not reflect an immediate cash investment by the insider.